{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:54:06Z","timestamp":1792698846594,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2011,5,19]],"date-time":"2011-05-19T00:00:00Z","timestamp":1305763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s11010-011-0878-2","type":"journal-article","created":{"date-parts":[[2011,10,14]],"date-time":"2011-10-14T00:08:02Z","timestamp":1318550882000},"page":"83-94","source":"Crossref","is-referenced-by-count":30,"title":["Curcumin suppresses growth of mesothelioma cells in vitro and in vivo, in part, by stimulating apoptosis"],"prefix":"10.1007","volume":"357","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun K.","family":"Rishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Polin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edi","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Albelda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey I.","family":"Pass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Wali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,19]]},"reference":[{"key":"878_CR1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1517\/14728210903074563","volume":"14","author":"C Belli","year":"2009","unstructured":"Belli C, Fennell D, Giovannini M, Gaudino G, Mutti L (2009) Malignant pleural mesothelioma: current treatments and emerging drugs. Expert Opin Emerg Drugs 14:423\u2013437","journal-title":"Expert Opin Emerg Drugs"},{"key":"878_CR2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ncponc1039","volume":"5","author":"DA Fennell","year":"2008","unstructured":"Fennell DA, Gaudino G, O\u2019Byrne KJ, Mutti L, van Meerbeeck J (2008) Advances in the systemic therapy of malignant pleural mesothelioma. Nat Clin Pract Oncol 5:136\u2013147","journal-title":"Nat Clin Pract Oncol"},{"key":"878_CR3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3816\/CLC.2003.n.023","volume":"5","author":"PA Janne","year":"2003","unstructured":"Janne PA (2003) Chemotherapy for malignant pleural mesothelioma. Clin Lung Cancer 5:98\u2013106","journal-title":"Clin Lung Cancer"},{"key":"878_CR4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s11912-005-0048-3","volume":"7","author":"RK Goudar","year":"2005","unstructured":"Goudar RK (2005) New therapeutic options for mesothelioma. Curr Oncol Rep 7:260\u2013265","journal-title":"Curr Oncol Rep"},{"key":"878_CR5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.hoc.2005.09.010","volume":"19","author":"LM Krug","year":"2005","unstructured":"Krug LM (2005) An overview of chemotherapy for mesothelioma. Hematol Oncol Clin North Am 19:1117\u20131136","journal-title":"Hematol Oncol Clin North Am"},{"key":"878_CR6","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1038\/sj.onc.1204828","volume":"20","author":"A Rienzo De","year":"2001","unstructured":"De Rienzo A, Balsara BR, Apostolou S, Jhanwar SC, Testa JR (2001) Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma. Oncogene 20:6245\u20136249","journal-title":"Oncogene"},{"key":"878_CR7","first-page":"955","volume":"9","author":"L Pylkkanen","year":"2002","unstructured":"Pylkkanen L, Sainio M, Ollikainen T, Mattson K, Nordling S, Carpen O, Linnainmaa K, Husgafvel-Pursiainen K (2002) Concurrent LOH at multiple loci in human malignant mesothelioma with preferential loss of NF2 gene region. Oncol Rep 9:955\u2013959","journal-title":"Oncol Rep"},{"key":"878_CR8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cancergencyto.2006.04.011","volume":"170","author":"M Musti","year":"2006","unstructured":"Musti M, Kettunen E, Dragonieri S, Lindholm P, Cavone D, Serio G, Knuutila S (2006) Cytogenetic and molecular genetic changes in malignant mesothelioma. Cancer Genet Cytogenet 170:9\u201315","journal-title":"Cancer Genet Cytogenet"},{"key":"878_CR9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/gcc.2870120203","volume":"12","author":"AW Langerak","year":"1995","unstructured":"Langerak AW, Williamson KA, Miyagawa K, Hagemeijer A, Versnel MA, Hastie ND (1995) Expression of the Wilm\u2019s tumor gene WT1 in human malignant mesothelioma cell lines and relationship to platelet-derived growth factor A and insulin-like growth factor 2 expression. Genes Chromosom Cancer 12:87\u201396","journal-title":"Genes Chromosom Cancer"},{"key":"878_CR10","first-page":"1947","volume":"30","author":"Y Adachi","year":"2010","unstructured":"Adachi Y, Yoshio-Hoshino N, Aoki C, Nishimoto N (2010) VEGF targeting in mesotheliomas using an interleukin-6 signal inhibitor based on adenovirus gene delivery. Anticancer Res 30:1947\u20131952","journal-title":"Anticancer Res"},{"key":"878_CR11","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2570::AID-CNCR12>3.0.CO;2-F","volume":"85","author":"Y Ohta","year":"1999","unstructured":"Ohta Y, Shridhar V, Kalemkerian GP, Bright RK, Watanabe Y, Pass HI (1999) Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma. Cancer 85:2570\u20132576","journal-title":"Cancer"},{"key":"878_CR12","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.athoracsur.2006.04.013","volume":"82","author":"BA Whitson","year":"2006","unstructured":"Whitson BA, Jacobson BA, Frizelle S, Patel MR, Yee D, Maddaus MA, Kratzke RA (2006) Effects of insulin-like growth factor-1 receptor inhibition in mesothelioma. Ann Thorac Surg 82:996\u20131002","journal-title":"Ann Thorac Surg"},{"key":"878_CR13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.thorsurg.2004.06.003","volume":"14","author":"HI Pass","year":"2004","unstructured":"Pass HI, Bocchetta M, carbone M (2004) Evidence of an important role for SV40 in mesothelioma. Thorac Surg Clin 14:489\u2013495","journal-title":"Thorac Surg Clin"},{"key":"878_CR14","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1158\/1078-0432.CCR-04-2109","volume":"11","author":"G Xia","year":"2005","unstructured":"Xia G, Kumar SR, Masood R, Koss M, Templeman C, Quinn D, Zhu S, Reddy R, Krasnoperov V, Gill PS (2005) Up-regulation of EphB4 in mesothelioma and its biological significance. Clin Cancer Res 11:4305\u20134315","journal-title":"Clin Cancer Res"},{"key":"878_CR15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1470-2045(04)01492-5","volume":"5","author":"DA Fennell","year":"2004","unstructured":"Fennell DA, Rudd RM (2004) Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development. Lancet Oncol 5:354\u2013362","journal-title":"Lancet Oncol"},{"key":"878_CR16","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrc1189","volume":"3","author":"YJ Surh","year":"2003","unstructured":"Surh YJ (2003) Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3:768\u2013780","journal-title":"Nat Rev Cancer"},{"key":"878_CR17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1158\/1940-6207.CAPR-08-0223","volume":"2","author":"EN Scott","year":"2009","unstructured":"Scott EN, Gescher AJ, Steward WP, Brown K (2009) Development of dietary phytochemical chemopreventive agents: biomarkers and choice of dose for early clinical trials. Cancer Prev Res 2:525\u2013530","journal-title":"Cancer Prev Res"},{"key":"878_CR18","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/carcin\/13.11.2183","volume":"13","author":"MT Huang","year":"1992","unstructured":"Huang MT, Wang ZY, Georgiadis CA, Laskin JD, Conney AH (1992) Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene. Carcinogenesis 13:2183\u20132186","journal-title":"Carcinogenesis"},{"key":"878_CR19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0065-2571(91)90025-H","volume":"31","author":"AH Conney","year":"1991","unstructured":"Conney AH, Lysz T, Ferraro T, Abidi TF, Manchand PS, Laskin JD, Huang MT (1991) Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv Enzyme Regul 31:385\u2013396","journal-title":"Adv Enzyme Regul"},{"key":"878_CR20","first-page":"5941","volume":"48","author":"MT Huang","year":"1988","unstructured":"Huang MT, Smart RC, Wong CQ, Conney AH (1988) Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O tetradecanoylphorbol-13-acetate. Cancer Res 48:5941\u20135946","journal-title":"Cancer Res"},{"key":"878_CR21","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.bcp.2008.07.031","volume":"76","author":"S Reuter","year":"2008","unstructured":"Reuter S, Eifes S, Dicato M, Aggarwal BB, Diederich M (2008) Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem Pharmacol 76:1340\u20131351","journal-title":"Biochem Pharmacol"},{"key":"878_CR22","first-page":"3293","volume":"25","author":"C Ramachandran","year":"2005","unstructured":"Ramachandran C, Rodriguez S, Ramachandran R, Raveendran Nair PK, Fonseca H, Khatib Z, Escalon E, Melnick SJ (2005) Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. Anticancer Res 25:3293\u20133302","journal-title":"Anticancer Res"},{"key":"878_CR23","doi-asserted-by":"crossref","first-page":"33422","DOI":"10.1074\/jbc.M303173200","volume":"278","author":"AK Rishi","year":"2003","unstructured":"Rishi AK, Zhang L, Boyanapalli M, Wali A, Mohammad RM, Yu Y, Fontana JA, Hatfield JS, Dawson MI, Majumdar APN, Reichert U (2003) Identification and characterization of a cell-cycle and apoptosis regulatory protein (CARP)-1 as a novel mediator of apoptosis signaling by retinoid CD437. J Biol Chem 278:33422\u201333435","journal-title":"J Biol Chem"},{"key":"878_CR24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/35055027","volume":"3","author":"P Liston","year":"2001","unstructured":"Liston P, Fong WG, Kelly NL, Toji S, Miyazaki T, Conte D, Tamai K, Craig CG, McBurney MW, Korneluk RG (2001) Identification of XAF1 as an antagonist of XIAP anti-caspase activity. Nat Cell Biol 3:128\u2013133","journal-title":"Nat Cell Biol"},{"key":"878_CR25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12029-009-9058-y","volume":"39","author":"J-P Lai","year":"2008","unstructured":"Lai J-P, Sandhu DS, Shire AM, Roberts LR (2008) The tumor suppressor function of human sulfatase 1 (SULF1) in carcinogenesis. J Gastrointest Cancer 39:149\u2013158","journal-title":"J Gastrointest Cancer"},{"key":"878_CR26","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMoa051185","volume":"353","author":"HI Pass","year":"2005","unstructured":"Pass HI, Lott D, Lonardo F, Harbut M, Liu Z, Tang N, Carbone M, Webb C, Wali A (2005) Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N Engl J Med 353:1564\u20131573","journal-title":"N Engl J Med"},{"key":"878_CR27","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1158\/0008-5472.CAN-06-2389","volume":"67","author":"E Suzuki","year":"2007","unstructured":"Suzuki E, Kim S, Cheung HK, Corbley MJ, Zhang X, Sun L, Shan F, Singh J, Lee WC, Albelda SM, Ling LE (2007) A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection. Cancer Res 67:2351\u20132359","journal-title":"Cancer Res"},{"key":"878_CR28","first-page":"6201","volume":"61","author":"M Odaka","year":"2001","unstructured":"Odaka M, Sterman D, Wiewrodt R, Zhang Y, Kiefer M, Amin KM, Gao G-P, Wilson JM, Barsoum J, Kaiser LR, Albelda SM (2001) Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-b gene therapy due to induction of systemic immunity. Cancer Res 61:6201\u20136212","journal-title":"Cancer Res"},{"key":"878_CR29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/0-387-29362-0_23","volume-title":"Bioinformatics and computational biology solutions using R and bioconductor","author":"GK Smyth","year":"2005","unstructured":"Smyth GK, Limma L (2005) Liner models for microarray data. In: Gentleman R, Carey V, Duoit S, Irizarry R, Huber W (eds) Bioinformatics and computational biology solutions using R and bioconductor. Springer, New York, pp 397\u2013420"},{"key":"878_CR30","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1371\/journal.pcbi.0030116","volume":"3","author":"AL Tarca","year":"2007","unstructured":"Tarca AL, Carey VJ, Chen XW, Romero R, Dr\u00e3ghici S (2007) Machine learning and its applications to biology. PLoS Comput Biol 3:e116","journal-title":"PLoS Comput Biol"},{"key":"878_CR31","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1158\/1535-7163.MCT-06-0653","volume":"6","author":"L Zhang","year":"2007","unstructured":"Zhang L, Levi E, Majumder P et al (2007) Transactivator of transcription tagged cell cycle and apoptosis regulatory protein-1 peptides suppress growth of human breast cancer cells in vitro and in vivo. Mol Cancer Ther 6:1661\u20131672","journal-title":"Mol Cancer Ther"},{"key":"878_CR32","doi-asserted-by":"crossref","unstructured":"Levi E, Zhang L, Aboukameel A, Rishi S, Mohammad RM, Polin L, Hatfield JS, and Rishi AK (2010) Cell cycle and apoptosis regulatory protein (CARP)-1 is a novel, adriamycin-inducible, diffuse large B-cell lymphoma (DLBL) growth suppressor. Cancer Chemother Pharmacol (in press)","DOI":"10.1007\/s00280-010-1442-6"},{"key":"878_CR33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00280-009-1181-8","volume":"66","author":"Y Wang","year":"2010","unstructured":"Wang Y, Rishi AK, Puliyappadamba VT, Sharma S, Yang H, Tarca A, Dou QP, Lonardo F, Ruckdeschel JC, Pass HI, Wali A (2010) Targeted proteasome inhibition by velcade induces apoptosis in human mesothelioma and breast cancer cell lines. Cancer Chemother Pharmacol 66:455\u2013466","journal-title":"Cancer Chemother Pharmacol"},{"key":"878_CR34","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00018-008-7452-4","volume":"65","author":"H Hatcher","year":"2008","unstructured":"Hatcher H, Planalp R, Cho J, Torti FM, Torti SV (2008) Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 65:1631\u20131652","journal-title":"Cell Mol Life Sci"},{"key":"878_CR35","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.bcp.2006.02.009","volume":"71","author":"BB Aggarwal","year":"2006","unstructured":"Aggarwal BB, Shishodia S (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71:1397\u20131421","journal-title":"Biochem Pharmacol"},{"key":"878_CR36","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s11064-007-9547-y","volume":"33","author":"PK Shukla","year":"2008","unstructured":"Shukla PK, Khanna VK, Ali MM, Khan MY, Srimal RC (2008) Anti-ischemic effect of curcumin in rat brain. Neurochem Res 33:1036\u20131043","journal-title":"Neurochem Res"},{"key":"878_CR37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/path.2120","volume":"211","author":"GJ Gordon","year":"2007","unstructured":"Gordon GJ, Mani M, Mukhopadhyay L, Dong L, Yeap BY, Sugarbaker DJ, Bueno R (2007) Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma. J Pathol 211:439\u2013446","journal-title":"J Pathol"},{"key":"878_CR38","doi-asserted-by":"crossref","first-page":"13188","DOI":"10.1074\/jbc.M512279200","volume":"281","author":"AK Rishi","year":"2006","unstructured":"Rishi AK, Zhang L, Yu Y, Jiang Y, Nautiyal J, Wali A, Fontana JA, Levi E, Majumdar APN (2006) Cell cycle and apoptosis regulatory protein (CARP)-1 is involved in apoptosis signaling by epidermal growth factor receptor. J Biol Chem 281:13188\u201313198","journal-title":"J Biol Chem"},{"key":"878_CR39","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.molcel.2008.08.001","volume":"31","author":"JH Kim","year":"2008","unstructured":"Kim JH, Yang CK, Heo K, Roeder RG, An W, Stallcup MR (2008) CCAR1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexes. Mol Cell 31:510\u2013519","journal-title":"Mol Cell"},{"key":"878_CR40","doi-asserted-by":"crossref","first-page":"20629","DOI":"10.1074\/jbc.M109.014332","volume":"284","author":"CY Ou","year":"2009","unstructured":"Ou CY, Kim JH, Yang CK, Stallcup MR (2009) Requirement of cell cycle and apoptosis regulator 1 for target gene activation by Wnt and {beta}-catenin and for anchorage-independent growth of human colon carcinoma cells. J Biol Chem 284:20629\u201320637","journal-title":"J Biol Chem"},{"key":"878_CR41","doi-asserted-by":"crossref","first-page":"22410","DOI":"10.1074\/jbc.M800643200","volume":"283","author":"Y Qian","year":"2008","unstructured":"Qian Y, Chen X (2008) ID1, inhibitor of differentiation\/DNA binding, is an effector of the p53-dependent DNA damage response pathway. J Biol Chem 283:22410\u201322416","journal-title":"J Biol Chem"},{"key":"878_CR42","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0021-9258(17)42146-6","volume":"269","author":"E Hara","year":"1994","unstructured":"Hara E, Yamaguchi T, Nojima H, Ide T, Campisi J, Okayama H, Oda K (1994) Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J Biol Chem 269:2139\u20132145","journal-title":"J Biol Chem"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-011-0878-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-011-0878-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-011-0878-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T20:46:06Z","timestamp":1639169166000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-011-0878-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,19]]},"references-count":42,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["878"],"URL":"https:\/\/doi.org\/10.1007\/s11010-011-0878-2","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,19]]}}}